[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"law-eurlex-reg_2007_737-de":3},{"abbreviation":4,"title":5,"source_type":6,"total":7,"offset":8,"entries":9},"reg_2007_737","zur Festlegung des Verfahrens für die Erneuerung der Aufnahme einer ersten Gruppe von Wirkstoffen in Anhang I der Richtlinie 91\u002F414\u002FEWG des Rates und zur Erstellung der Liste dieser Wirkstoffe","eurlex",48,0,[10,15,18,21,24,27,30,33,36,39,42,45,48,52,56,60,64,68,72,76,80,84,88,92,96,100,104,108,112,116,121,124,127,130,133,136,139,142,145,148,151,154,157,160,163,166,169,172],{"norm_key":11,"title":12,"chapter":13,"slug":14},"ErwGr. 1",null,"Erwägungsgründe","erwgr-1",{"norm_key":16,"title":12,"chapter":13,"slug":17},"ErwGr. 2","erwgr-2",{"norm_key":19,"title":12,"chapter":13,"slug":20},"ErwGr. 3","erwgr-3",{"norm_key":22,"title":12,"chapter":13,"slug":23},"ErwGr. 4","erwgr-4",{"norm_key":25,"title":12,"chapter":13,"slug":26},"ErwGr. 5","erwgr-5",{"norm_key":28,"title":12,"chapter":13,"slug":29},"ErwGr. 6","erwgr-6",{"norm_key":31,"title":12,"chapter":13,"slug":32},"ErwGr. 7","erwgr-7",{"norm_key":34,"title":12,"chapter":13,"slug":35},"ErwGr. 8","erwgr-8",{"norm_key":37,"title":12,"chapter":13,"slug":38},"ErwGr. 9","erwgr-9",{"norm_key":40,"title":12,"chapter":13,"slug":41},"ErwGr. 10","erwgr-10",{"norm_key":43,"title":12,"chapter":13,"slug":44},"ErwGr. 11","erwgr-11",{"norm_key":46,"title":12,"chapter":13,"slug":47},"ErwGr. 12","erwgr-12",{"norm_key":49,"title":50,"chapter":12,"slug":51},"Art. 1","Anwendungsbereich","art-1",{"norm_key":53,"title":54,"chapter":12,"slug":55},"Art. 2","Begriffsbestimmungen","art-2",{"norm_key":57,"title":58,"chapter":12,"slug":59},"Art. 3","Benannte Behörde des Mitgliedstaats","art-3",{"norm_key":61,"title":62,"chapter":12,"slug":63},"Art. 4","Mitteilung","art-4",{"norm_key":65,"title":66,"chapter":12,"slug":67},"Art. 5","Zulässigkeit von Anträgen und Veröffentlichung von Daten über Antragsteller","art-5",{"norm_key":69,"title":70,"chapter":12,"slug":71},"Art. 6","Übermittlung von Daten","art-6",{"norm_key":73,"title":74,"chapter":12,"slug":75},"Art. 7","Nachträgliche Vorlage","art-7",{"norm_key":77,"title":78,"chapter":12,"slug":79},"Art. 8","Ende der Teilnahme","art-8",{"norm_key":81,"title":82,"chapter":12,"slug":83},"Art. 9","Angaben von Dritten","art-9",{"norm_key":85,"title":86,"chapter":12,"slug":87},"Art. 10","Bewertung durch den berichterstattenden Mitgliedstaat","art-10",{"norm_key":89,"title":90,"chapter":12,"slug":91},"Art. 11","Zugang zum Bewertungsbericht","art-11",{"norm_key":93,"title":94,"chapter":12,"slug":95},"Art. 12","Beurteilung des Bewertungsberichts","art-12",{"norm_key":97,"title":98,"chapter":12,"slug":99},"Art. 13","Vorlage eines Richtlinien- oder Entscheidungsentwurfs","art-13",{"norm_key":101,"title":102,"chapter":12,"slug":103},"Art. 14","Zugang zum Beurteilungsbericht","art-14",{"norm_key":105,"title":106,"chapter":12,"slug":107},"Art. 15","Gebühren","art-15",{"norm_key":109,"title":110,"chapter":12,"slug":111},"Art. 16","Andere Steuern, Abgaben oder Gebühren","art-16",{"norm_key":113,"title":114,"chapter":12,"slug":115},"Art. 17","Inkrafttreten","art-17",{"norm_key":117,"title":118,"chapter":119,"slug":120},"Anhang I","Liste der in Artikel 1 genannten Wirkstoffe und der für sie benannten berichterstattenden und berichtmiterstattenden Mitgliedstaaten","Anhänge","anhang-i",{"norm_key":122,"title":123,"chapter":119,"slug":12},"Anhang II.1","BELGIEN",{"norm_key":125,"title":126,"chapter":119,"slug":12},"Anhang II.2","TSCHECHISCHE REPUBLIK",{"norm_key":128,"title":129,"chapter":119,"slug":12},"Anhang II.3","DEUTSCHLAND",{"norm_key":131,"title":132,"chapter":119,"slug":12},"Anhang II.4","IRLAND",{"norm_key":134,"title":135,"chapter":119,"slug":12},"Anhang II.5","SPANIEN",{"norm_key":137,"title":138,"chapter":119,"slug":12},"Anhang II.6","FRANKREICH",{"norm_key":140,"title":141,"chapter":119,"slug":12},"Anhang II.7","LITAUEN",{"norm_key":143,"title":144,"chapter":119,"slug":12},"Anhang II.8","UNGARN",{"norm_key":146,"title":147,"chapter":119,"slug":12},"Anhang II.9","NIEDERLANDE",{"norm_key":149,"title":150,"chapter":119,"slug":12},"Anhang II.10","POLEN",{"norm_key":152,"title":153,"chapter":119,"slug":12},"Anhang II.11","SLOWENIEN",{"norm_key":155,"title":156,"chapter":119,"slug":12},"Anhang II.12","SLOWAKEI",{"norm_key":158,"title":159,"chapter":119,"slug":12},"Anhang II.13","SCHWEDEN",{"norm_key":161,"title":162,"chapter":119,"slug":12},"Anhang II.14","VEREINIGTES KÖNIGREICH",{"norm_key":164,"title":165,"chapter":119,"slug":12},"Anhang III.1","Antragstellung für einen Wirkstoff gemäß Artikel 4",{"norm_key":167,"title":168,"chapter":119,"slug":12},"Anhang III.2","1. Angaben zum Antragsteller",{"norm_key":170,"title":171,"chapter":119,"slug":12},"Anhang III.3","2. Angaben zur Identifizierung des Wirkstoffs",{"norm_key":173,"title":174,"chapter":119,"slug":175},"Anhang IV","Kriterien für die Annahme von Anträgen gemäß Artikel 4","anhang-iv"]